Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04618393
Title A Study of EMB-02 in Participants With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Shanghai EpimAb Biotherapeutics Co., Ltd.
Indications

melanoma

Advanced Solid Tumor

Therapies

EMB-02

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.